Raphaël Ceccaldi
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 2%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
Papers in
- Oncology 11
- PARP inhibition in cancer therapy 8
- Cancer-related Molecular Pathways 3
-
- Carcinogens and Genotoxicity Assessment 4
- Co-authors
- Alan D. D’AndreaBeatrice RondinelliPanagiotis A. KonstantinopoulosGeoffrey I. ShapiroPrabha SarangiKevin W. O’ConnorSimon J. BoultonBenjamin Primack
- Journals
- Molecular Cell (4 papers)Nature Reviews Molecular Cell Biology (2 papers)Journal of Clinical Investigation (2 papers)Nature (2 papers)Blood (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Raphaël Ceccaldi
22 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 1.9k
- Molecular Biology 3.5k
- Reproductive Medicine 370
- Cancer Research 576
- Aging 52
Countries citing papers authored by Raphaël Ceccaldi
This map shows the geographic impact of Raphaël Ceccaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Ceccaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Ceccaldi more than expected).
Fields of papers citing papers by Raphaël Ceccaldi
This network shows the impact of papers produced by Raphaël Ceccaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Ceccaldi. The network helps show where Raphaël Ceccaldi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Raphaël Ceccaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2025 | 3 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 42 | |
| 5 | 2023 | 55 | |
| 6 | A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors Hit paper breakdown → | 2021 | 226 |
| 7 | 2018 | 99 | |
| 8 | 2017 | 256 | |
| 9 | The Fanconi anaemia pathway: new players and new functions Hit paper breakdown → | 2016 | 492 |
| 10 | 2016 | 147 | |
| 11 | 2016 | 105 | |
| 12 | Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair Hit paper breakdown → | 2015 | 648 |
| 13 | Repair Pathway Choices and Consequences at the Double-Strand Break Hit paper breakdown → | 2015 | 1081 |
| 14 | 2015 | 97 | |
| 15 | 2014 | 46 | |
| 16 | 2013 | 27 | |
| 17 | 2012 | 20 | |
| 18 | 2012 | 231 | |
| 19 | 2010 | 49 | |
| 20 | 2010 | 3 |
About Raphaël Ceccaldi
Raphaël Ceccaldi is a scholar working on Oncology, Cancer Research, Molecular Biology, Cell Biology and Hematology, having authored 22 papers that have together received 4.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (18 papers), PARP inhibition in cancer therapy (8 papers), CRISPR and Genetic Engineering (6 papers), Carcinogens and Genotoxicity Assessment (4 papers), Cancer-related Molecular Pathways (3 papers), Microtubule and mitosis dynamics (3 papers), Genomics and Chromatin Dynamics (3 papers) and Plant Genetic and Mutation Studies (2 papers). The work is most often cited by research in Oncology (1.9k citations), Molecular Biology (3.5k citations), Reproductive Medicine (370 citations), Cancer Research (576 citations) and Aging (52 citations). Raphaël Ceccaldi has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Alan D. D’Andrea, Beatrice Rondinelli, Panagiotis A. Konstantinopoulos, Geoffrey I. Shapiro, Prabha Sarangi, Kevin W. O’Connor, Simon J. Boulton, Benjamin Primack, Ravindra Amunugama and Mark I.R. Petalcorin. Their work appears in journals such as Molecular Cell, Nature Reviews Molecular Cell Biology, Journal of Clinical Investigation, Nature and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.